Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
6.77
-0.21 (-3.01%)
Apr 3, 2026, 3:00 PM CST

SHA:600223 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,8827,4827,6859,79010,76513,371
Market Cap Growth
-7.13%-2.65%-21.50%-9.06%-19.49%55.57%
Enterprise Value
5,0335,6335,88112,41115,21321,219
Last Close Price
6.777.367.519.3410.2712.69
PE Ratio
37.6139.8531.5632.27236.8436.95
Forward PE
21.6633.6433.6433.6433.6433.64
PS Ratio
1.892.051.932.140.831.08
PB Ratio
1.411.531.612.091.932.06
P/TBV Ratio
1.781.932.032.643.203.07
P/FCF Ratio
41.5145.13107.5837.2512.942.04
P/OCF Ratio
24.9227.0933.6120.6510.791.95
EV/Sales Ratio
1.381.541.482.711.181.72
EV/EBITDA Ratio
15.9218.1119.0734.1421.9829.09
EV/EBIT Ratio
24.1827.0627.3954.5126.4333.32
EV/FCF Ratio
30.3633.9882.3347.2318.293.23
Debt / Equity Ratio
0.040.040.060.471.391.43
Debt / EBITDA Ratio
0.630.630.915.8111.0912.71
Debt / FCF Ratio
1.211.214.008.309.301.41
Net Debt / Equity Ratio
-0.52-0.52-0.560.100.610.64
Net Debt / EBITDA Ratio
-8.20-8.20-8.631.234.945.69
Net Debt / FCF Ratio
-15.39-15.39-37.261.714.110.63
Asset Turnover
--0.580.140.220.20
Inventory Turnover
--3.490.110.210.20
Quick Ratio
--3.152.240.120.13
Current Ratio
--3.752.491.101.15
Return on Equity (ROE)
4.91%4.91%6.26%7.15%1.08%6.05%
Return on Assets (ROA)
--1.94%0.43%0.60%0.65%
Return on Invested Capital (ROIC)
7.42%7.78%5.07%2.86%1.46%3.31%
Return on Capital Employed (ROCE)
--4.40%4.20%7.30%6.20%
Earnings Yield
2.73%2.51%3.17%3.10%0.42%2.71%
FCF Yield
2.41%2.22%0.93%2.68%7.73%49.11%
Dividend Yield
1.72%-1.47%1.07%1.07%0.87%
Payout Ratio
34.72%34.72%75.38%160.84%2585.08%556.88%
Buyback Yield / Dilution
-2.80%-2.80%-0.34%11.01%-9.90%-2.00%
Total Shareholder Return
-1.08%-2.80%1.13%12.08%-8.83%-1.13%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.